Lipella Pharmaceuticals Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $80 | $136,431 | $145 | $120 |
Gross Profit | -966 | 135,769 | 145 | 120 |
EBITDA | -1,443 | -936 | -1,191 | -688 |
EBIT | -1,444 | -938 | -1,191 | -688 |
Net Income | -1,444,637 | -938,146 | -1,191 | -688 |
Net Change In Cash | 80 | 136,431 | 145 | 120 |
Free Cash Flow | -2,958,026 | -918 | -1,388 | -15,149 |
Cash | 1,353 | 1,186 | 2,105 | 3,293 |
Basic Shares | 1,119 | 7,605 | 7,292 | 6,053 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $449 | $184 | $259 | $961 |
Gross Profit | -2,589 | -2,363 | -1,197 | -14 |
EBITDA | -4,606 | -2,588 | -1,858 | -53 |
EBIT | -4,608 | -5,177 | -3,774 | -110 |
Net Income | -4,618 | -2,596 | -1,872 | -66 |
Net Change In Cash | 449 | 184 | 259 | 961 |
Free Cash Flow | -3,164 | -1,831 | -989 | -28 |
Cash | 3,293 | 5,121 | 1,413 | 606 |
Basic Shares | 6,003 | 5,743 | 5,743 | 5,693 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.29 |
2024-06-30 | -$0.98 |
2024-03-31 | -$0.16 |
2023-12-31 | -$0.91 |
